Question 1

Has Moraima Trujillo received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $6,604,301 in general payments to Moraima Trujillo across 1,129 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Moraima Trujillo did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Moraima Trujillo come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
AbbVie(2 entities)	314	$3,281,801
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	491	$1,343,165
Teva Pharmaceuticals USA, Inc.	106	$990,522
E.r. Squibb & Sons, L.L.C.	9	$560,612
Janssen Research & Development, LLC	26	$230,695
Otsuka America Pharmaceutical, Inc.	72	$62,280
Hoffmann-la Roche Limited	13	$59,731
Johnson & Johnson	58	$43,690
Otsuka Pharmaceutical Development & Commercialization, Inc.	5	$16,800
Alkermes, Inc.	19	$10,586
Sunovion Pharmaceuticals Inc.	4	$4,135
Indivior Inc.	7	$173
Braeburn Inc.	2	$45
Axsome Therapeutics, Inc.	1	$25
Tempus AI, Inc	1	$24
Phadia US Inc.	1	$19

Moraima Trujillo

Payments from drug & device makers

Who reported the general payments

How this compares

Other psychiatry in Coral Gables